The genetic manipulation of Fbxo4 successfully alters the stability of cyclin D1 protein, which is evidenced by the accumulation of cyclin D1 protein in human ESCC tissues and melanoma cells with defective Fbxo4 [79]. The gene discussed is FBXO4; the disease is esophageal squamous cell carcinoma.